ELOA-AS1

Across TCGA pan-cancer cohorts, ELOA-AS1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated ELOA-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher ELOA-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ELOA-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and LUAD show a favorable association.

READ, KICH, and LUAD are the cancer types where ELOA-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	II,III,IV	0.767	0.431	<.001	96	view →
KICH	OS	Tertile	All	0.820	1.000	.003	86	view →
LUAD	DFS	Median	All	0.847	0.732	<.001	62	view →
LGG	DFS	Median	All	0.652	0.822	<.001	51	view →
ACC	DFS	Tertile	All	0.502	0.941	.001	50	view →
KIRP	DFS	Median	All	0.806	0.922	.007	34	view →
MESO	DFS	Quartile	All	0.561	0.302	.008	30	view →
UVM	DFS	Tertile	III,IV	0.283	0.856	.007	26	view →
UCEC	DFS	Tertile	III,IV	0.755	0.462	.026	22	view →
CHOL	DFS	Median	All	0.728	0.122	.002	21	view →
KIRC	DFS	Tertile	IV	0.222	0.455	.017	20	view →
PCPG	DFS	Median	All	0.941	0.820	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

ELOA-AS1–READ (DFS)

Open the READ breakdown →